share_log

騰盛博藥-B:(1)非執行董事辭任;(2)委任獨立非執行董事;及(3)審核與風險委員會、提名委員會及戰略委員會組成變動

BRII-B: (1) RESIGNATION OF NON-EXECUTIVE DIRECTOR; (2) APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR; AND (3) CHANGE IN COMPOSITION OF AUDIT AND RISK COMMITTEE, NOMINATION COMMITTEE AND STRATEGY COMMITTEE

Aug 31, 2022 19:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more